Rho-associated coiled-coil kinase 1 activation mediates amyloid precursor protein site-specific Ser655 phosphorylation and triggers amyloid pathology
Open accessAbstract
Rho‐associated coiled‐coil kinase 1 (ROCK1) is proposed to be implicated in Aβ suppression; however, the role for ROCK1 in amyloidogenic metabolism of amyloid precursor protein (APP) to produce Aβ was unknown. In the present study, we showed that ROCK1 kinase activity and its APP binding were enhanced in AD brain, resulting in increased β‐secretase cleavage of APP. Furthermore, we firstly confirmed that APP served as a substrate for ROCK1 and its major phosphorylation site was located at Ser655. The increased level of APP Ser655 phosphorylation was observed in the brain of APP/PS1 mice and AD patients compared to controls. Moreover, blockade of APP Ser655 phosphorylation, or inhibition of ROCK1 activity with either shRNA knockdown or Y‐27632, ameliorated amyloid pathology and improved learning and memory in APP/PS1 mice. These findings suggest that activated ROCK1 targets APP Ser655 phosphorylation, which promotes amyloid processing and pathology. Inhibition of ROCK1 could be a potential therapeutic approach for AD.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
ROCK directly interacts with APP and phosphorylates its Ser655 residue, promoting amyloidogenic processing of APP by increasing the interaction of BACE1 with APP.
“It was recently reported that ROCK directly interacts with APP and phosphorylates its Ser655 residue, promoting amyloidogenic processing of APP by increasing the interaction of β-site APP cleaving enzyme 1 (BACE1) with APP [194].”
From RhoA Signaling in Neurodegenerative Diseases (2022) · cites this paper as [194]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
η-Secretase processing of APP inhibits neuronal activity in the hippocampus
Willem, M., Tahirovic, S., Busche, M. A., Ovsepian, S. V., Chafai, M., Kootar, S., Hornburg, D., Evans, L. D. B., Moore, S., Daria, A., et al. (2015) · Nature · doi:10.1038/nature14864 · Cited by 398 · see citing works
Flagged first, then by citations
Research works printed but not linked: 41
- Ahmed, T., Zahid, S., Mahboob, A., & Farhat, S. M. (2017). Cholinergic system and post‐translational modifications: An insight on the role in Alzheimer's disease. Current Neuropharmacology, 15, 480– 494. 10.2174/1570159X14666160325121145 27012953 PMC5543671 · DOI
- Ando, K., Iijima, K. I., Elliott, J. I., Kirino, Y., & Suzuki, T. (2001). Phosphorylation‐dependent regulation of the interaction of amyloid precursor protein with Fe65 affects the production of beta‐amyloid. Journal of Biological Chemistry, 276, 40353– 40361. 11517218
- Benseny‐Cases, N., Alvarez‐Marimon, E., Castillo‐Michel, H., Cotte, M., Falcon, C., & Cladera, J. (2018). Synchrotron‐based Fourier transform infrared microspectroscopy (muFTIR) study on the effect of Alzheimer's Abeta amorphous and fibrillar aggregates on PC12 cells. Analytical Chemistry, 90, 2772– 2779. 29359921
- Boland, S., Bourin, A., Alen, J. O., Geraets, J., Schroeders, P., Castermans, K., … Defert, O. (2015). Design, synthesis and biological evaluation of novel, highly active soft ROCK inhibitors. Journal of Medicinal Chemistry, 58, 4309– 4324. 10.1021/acs.jmedchem.5b00308 25898023 · DOI
- Borrajo, A., Rodriguez‐Perez, A. I., Villar‐Cheda, B., Guerra, M. J., & Labandeira‐Garcia, J. L. (2014). Inhibition of the microglial response is essential for the neuroprotective effects of Rho‐kinase inhibitors on MPTP‐induced dopaminergic cell death. Neuropharmacology, 85, 1– 8. 10.1016/j.neuropharm.2014.05.021 24878243 · DOI · Paper page
- Citron, B. A., Dennis, J. S., Zeitlin, R. S., & Echeverria, V. (2008). Transcription factor Sp1 dysregulation in Alzheimer's disease. Journal of Neuroscience Research, 86, 2499– 2504. 10.1002/jnr.21695 18449948 · DOI · Paper page
- Deyts, C., Thinakaran, G., & Parent, A. T. (2016). APP receptor? To be or not to be. Trends in Pharmacological Sciences, 37, 390– 411. 10.1016/j.tips.2016.01.005 26837733 PMC4846520 · DOI
- Fujisawa, K., Fujita, A., Ishizaki, T., Saito, Y., & Narumiya, S. (1996). Identification of the Rho‐binding domain of p160ROCK, a Rho‐associated coiled‐coil containing protein kinase. Journal of Biological Chemistry, 271, 23022– 23028. 8798490
- Goedert, M., & Spillantini, M. G. (2006). A century of Alzheimer's disease. Science, 314, 777– 781. 10.1126/science.1132814 17082447 · DOI
- Green, J., Cao, J., Bandarage, U. K., Gao, H., Court, J., Marhefka, C., … Rodems, S. (2015). Design, synthesis, and structure‐activity relationships of pyridine‐based Rho kinase (ROCK) inhibitors. Journal of Medicinal Chemistry, 58, 5028 10.1021/acs.jmedchem.5b00424 26039570 · DOI
- Gupta, V., Gupta, N., Shaik, I. H., Mehvar, R., Mcmurtry, I. F., Oka, M., … Ahsan, F. (2013). Liposomal fasudil, a rho‐kinase inhibitor, for prolonged pulmonary preferential vasodilation in pulmonary arterial hypertension. Journal of Controlled Release, 167, 189 10.1016/j.jconrel.2013.01.011 23353807 PMC3632285 · DOI
- Henderson, B. W., Gentry, E. G., Rush, T., Troncoso, J. C., Thambisetty, M., Montine, T. J., & Herskowitz, J. H. (2016). Rho‐associated protein kinase 1 (ROCK1) is increased in Alzheimer's disease and ROCK1 depletion reduces amyloid‐β levels in brain. Journal of Neurochemistry, 138, 525– 531. 10.1111/jnc.13688 27246255 PMC4980252 · DOI · Paper page
- Herskowitz, J. H., Seyfried, N. T., Duong, D. M., Xia, Q., Rees, H. D., Gearing, M., … Levey, A. I. (2010). Phosphoproteomic analysis reveals site‐specific changes in GFAP and NDRG2 phosphorylation in frontotemporal lobar degeneration. Journal of Proteome Research, 9, 6368– 6379. 10.1021/pr100666c 20886841 PMC2997170 · DOI
- Homan, K. T., & Tesmer, J. J. (2015). Molecular basis for small molecule inhibition of G protein‐coupled receptor kinases. Acs Chemical Biology, 10, 246– 256. 24984143 PMC4301174
- Hu, Y. B., Zou, Y., Huang, Y., Zhang, Y. F., Lourenco, G. F., Chen, S. D., … Ren, R. J.. (2016). ROCK1 is associated with Alzheimer's disease‐specific plaques, as well as enhances autophagosome formation but not autophagic Aβ clearance. Frontiers in Cellular Neuroscience, 10, 253. 27853422 PMC5089992
- Lacampagne, A., Liu, X., Reiken, S., Bussiere, R., Meli, A. C., Lauritzen, I., … Marks, A. R. (2017). Post‐translational remodeling of ryanodine receptor induces calcium leak leading to Alzheimer's disease‐like pathologies and cognitive deficits. Acta Neuropathologica, 134, 749– 767. 28631094
- Lane, R. F., Gatson, J. W., Small, S. A., Ehrlich, M. E., & Gandy, S. (2010). Protein kinase C and rho activated coiled coil protein kinase 2 (ROCK2) modulate Alzheimer's APP metabolism and phosphorylation of the Vps10‐domain protein, SorL1. Molecular Neurodegeneration, 5, 62 10.1186/1750-1326-5-62 21192821 PMC3036620 · DOI
- Lauritzen, I., Pardossi‐Piquard, R., Bourgeois, A., Pagnotta, S., Biferi, M.‐G., Barkats, M., … Checler, F. (2016). Intraneuronal aggregation of the β‐CTF fragment of APP (C99) induces Aβ‐independent lysosomal‐autophagic pathology. Acta Neuropathologica, 132, 257– 276. 10.1007/s00401-016-1577-6 27138984 PMC4947121 · DOI · Paper page
- Lee, M. S., Kao, S. C., Lemere, C. A., Xia, W., Tseng, H. C., Zhou, Y., … Tsai, L. H. (2003). APP processing is regulated by cytoplasmic phosphorylation. Journal of Cell Biology, 163, 83– 95. 10.1083/jcb.200301115 14557249 PMC2173445 · DOI
- Liu, L., Li, G., Li, Q., Jin, Z., Zhang, L., Zhou, J., … Gao, N. (2013). Triptolide induces apoptosis in human leukemia cells through caspase‐3‐mediated ROCK1 activation and MLC phosphorylation. Cell Death and Disease, 4, e941 10.1038/cddis.2013.469 24309928 PMC3877542 · DOI
- Loirand, G. (2015). Rho kinases in health and disease: From basic science to translational research. Pharmacological Reviews, 67, 1074 10.1124/pr.115.010595 26419448 · DOI
- Marcelli, S., Corbo, M., Iannuzzi, F., Negri, L., Blandini, F., Nisticò, R., & Feligioni, M. (2017). The involvement of post‐translational modifications in Alzheimer's disease. Current Alzheimer Research, 15, 313– 335. 28474569
- Müller, T., Meyer, H. E., Egensperger, R., & Marcus, K. (2008). The amyloid precursor protein intracellular domain (AICD) as modulator of gene expression, apoptosis, and cytoskeletal dynamics—Relevance for Alzheimer's disease. Progress in Neurobiology., 85, 393– 406. 10.1016/j.pneurobio.2008.05.002 18603345 · DOI
- Narayanan, K. L., Chopra, V., Rosas, H. D., Malarick, K., & Hersch, S. (2016). Rho kinase pathway alterations in the brain and leukocytes in Huntington's disease. Molecular Neurobiology, 53, 2132– 2140. 10.1007/s12035-015-9147-9 25941073 PMC4823347 · DOI · Paper page
- O’Brien, R. J., & Wong, P. C. (2011). Amyloid precursor protein processing and Alzheimer’s disease. Annual Review of Neuroscience, 34, 185– 204. 10.1146/annurev-neuro-061010-113613 PMC3174086 21456963 · DOI · Paper page
- Olson, M. F. (2008). Applications for ROCK kinase inhibition. Current Opinion in Cell Biology, 20, 242– 248. 10.1016/j.ceb.2008.01.002 18282695 PMC2377343 · DOI
- Pastorino, L., Ma, S. L., Balastik, M., Huang, P., Pandya, D., Nicholson, L., & Lu, K. P. (2012). Alzheimer's disease‐related loss of Pin1 function influences the intracellular localization and the processing of AβPP. Journal of Alzheimers Disease Jad, 30, 277 10.3233/JAD-2012-111259 22430533 · DOI
- Pedrini, S., Carter, T. L., Prendergast, G., Petanceska, S., Ehrlich, M. E., & Gandy, S. (2005). Modulation of statinactivated shedding of Alzheimer APP ectodomain by ROCK. PLoS Med, 2(1), e18 10.1371/journal.pmed.0020018. 15647781 PMC543463 · DOI · Paper page
- Peng, H., Cao, J., Yu, R., Danesh, F., Wang, Y., Mitch, W. E., … Hu, Z. (2016). CKD stimulates muscle protein loss via Rho‐associated protein kinase 1 activation. Journal of the American Society of Nephrology, 27, 509– 519. 26054539 PMC4731120
- Rafii, M. S., & Aisen, P. S. (2015). Advances in Alzheimer’s disease drug development. BMC Medicine, 13, 62 10.1186/s12916-015-0297-4 25857341 PMC4373002 · DOI
- Schedin‐Weiss, S., Winblad, B., & Tjernberg, L. O. (2014). The role of protein glycosylation in Alzheimer disease. FEBS Journal, 281, 46– 62. 10.1111/febs.12590 24279329 · DOI
- Shibata, R., Kai, H., Seki, Y., Kusaba, K., Takemiya, K., Koga, M., … Imaizumi, T. (2003). Rho‐kinase inhibition reduces neointima formation after vascular injury by enhancing Bax expression and apoptosis. Journal of Cardiovascular Pharmacology, 42, 43– 47. 10.1097/00005344-200312001-00011 14871028 · DOI
- Surma, M., Handy, C., Chang, J., Kapur, R., Wei, L., & Shi, J. (2014). ROCK1 deficiency enhances protective effects of antioxidants against apoptosis and cell detachment. PLoS ONE, 9, e90758 10.1371/journal.pone.0090758 24595357 PMC3942480 · DOI
- Tatenhorst, L., Eckermann, K., Dambeck, V., Fonseca‐Ornelas, L., Walle, H., Lopes da Fonseca, T., … Lingor, P. (2016). Fasudil attenuates aggregation of α‐synuclein in models of Parkinson's disease. Acta Neuropathologica Communications, 4, 39 10.1186/s40478-016-0310-y 27101974 PMC4840958 · DOI · Paper page
- Turner, P. R., O'Connor, K., Tate, W. P., & Abraham, W. C. (2003). Roles of amyloid precursor protein and its fragments in regulating neural activity, plasticity and memory. Progress in Neurobiology, 70, 1– 32. 10.1016/S0301-0082(03)00089-3 12927332 · DOI
- Villar‐Cheda, B., Dominguez‐Meijide, A., Joglar, B., Rodriguez‐Perez, A. I., Guerra, M. J., & Labandeira‐Garcia, J. L. (2012). Involvement of microglial RhoA/Rho‐kinase pathway activation in the dopaminergic neuron death. Role of angiotensin via angiotensin type 1 receptors. Neurobiology of Disease, 47, 268– 279. 22542954
- Vingtdeux, V., Hamdane, M., Gompel, M., Bégard, S., Drobecq, H., Ghestem, A., … Sergeant, N. (2005). Phosphorylation of amyloid precursor carboxy‐terminal fragments enhances their processing by a gamma‐secretase‐dependent mechanism. Neurobiology of Disease, 20, 625– 637. 10.1016/j.nbd.2005.05.004 15936948 · DOI
- Yan, P., Bero, A. W., Cirrito, J. R., Xiao, Q., Hu, X., Wang, Y., … Lee, J. M. (2009). Characterizing the appearance and growth of amyloid plaques in APP/PS1 mice. Journal of Neuroscience, 29, 10706– 10714. 10.1523/JNEUROSCI.2637-09.2009 19710322 PMC2756291 · DOI · Paper page
- Yanuaryska, R. D., Miyoshi, K., Adiningrat, A., Horiguchi, T., Tanimura, A., Hagita, H., & Noma, T. (2014). Sp6 regulation of Rock1 promoter activity in dental epithelial cells. The Journal of Medical Investigation, 61, 306– 317. 10.2152/jmi.61.306 25264049 · DOI
- Zhang, R., Feng, X., Zhan, M., Huang, C., Chen, K., Tang, X., … Lei, M. (2016). Transcription factor Sp1 promotes the expression of porcine ROCK1 gene. International Journal of Molecular Sciences, 17 10.3390/ijms17010112 PMC4730353 26784181 · DOI
- Zhou, Y., Su, Y., Li, B., Liu, F., Ryder, J. W., Wu, X., … Ni, B. (2003). Nonsteroidal anti-inflammatory drugs can lower amyloidogenic Abeta42 by inhibiting Rho. Science, 302(5648), 1215– 1217. 10.1126/science.1090154. 14615541 · DOI · Paper page
Cited by
Sorted by citations
RhoA Signaling in Neurodegenerative Diseases
Schmidt, S. I., Blaabjerg, M., Freude, K., & Meyer, M. (2022) · Cells · doi:10.3390/cells11091520 · Cited by 110 · see citing works
- Authors
- Hu, Y., Ren, R., Zhang, Y., Huang, Y., Cui, H., Ma, C., Qiu, W., Wang, H., Cui, P., Chen, H., & Wang, G.
- Affiliations
- Shanghai Jiao Tong University (CN)
- Capital Medical University (CN)
- Department of Neurology Neuroscience Institute Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine Shanghai China
- Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
- Department of Human Anatomy, Histology and Embryology, Institute of Basic Medical Sciences, Neuroscience Center, Chinese Academy of Medical Sciences, School of Basic Medicine Peking Union Medical College Beijing China
- Corresponding author
- Chen, Hong‐Zhuan
- Wang, Gang
- Venue
- Aging Cell
- Publisher
- Wiley
- Published
- 2019-07-09
- Volume
- 18
- Issue
- 5
- Pages
- e13001-e13001
- ISSN
- 1474-9718 (ISSN-L)
- 1474-9726
- PMC
- PMC6718535
- OpenAlex
- W2961532768
- Cited by
- 33
- References
- 1
- Citations by year
- 2026: 7 · 2025: 6 · 2024: 7 · 2023: 3 · 2022: 2 · 2021: 7 · 2019: 1
- FWCI
- 1.68
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Aging Cell (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- National Natural Science Foundation of China (81171027, 81200842, 81573401, 81671043, 81501086)
- Shanghai Education Development Foundation
- Chinese Academy of Medical Sciences
- Topics
- Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
- Keywords
- ROCK1, amyloid precursor protein, amyloid-beta, Alzheimer's disease, APP/PS1 mice, Y-27632, learning and memory, amyloid pathology
- MeSH terms
- Alzheimer Disease, Amides, Animals, Cells, Cultured, Humans, Mice, Inbred C57BL, Mice, Transgenic, Phosphorylation, Phosphoserine, Pyridines, Amyloid beta-Peptides, Amyloid beta-Protein Precursor, RNA, Small Interfering, Protein Kinase Inhibitors, Mice, rho-Associated Kinases, HEK293 Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review